Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density can also be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis or its precursor, osteopenia.
Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density can also be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis or its precursor, osteopenia.
Thanks for writing. We will be in touch shortly to address any questions, concerns, or technical difficulties you may have.
There are no live broadcasts scheduled.
See what's new on Cornell Video and find out what's coming up next — and how you can take part. Subscribe to receive weekly Cornell Video updates via email.
Our hamsters have processed your subscription request and advise that the weekly update messages will contain details on unsubscribing in case you need them.
Our hamsters have processed your request and advise that a summary has been sent to the email address entered.
tdb
Enter your email below to be notified when this event begins
You should receive an email confirmation shortly.
We will send you an email reminder before the show begins.
You may request additional reminders for other times if you wish.
You can also add this event to a calendar of your choice
For iCal, an .ics file will be downloaded to your computer or device. You may need to take additional steps to add the event to your personal calendar.
Let us know your preferences and our accommodating hamsters will snap to it!
Enter your email below to be notified when new related videos become available.
You should receive an email confirmation shortly.
We will send you an email message when new related videos are posted.